Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer

Prostate cancer (PCa) clinical heterogeneity underscores tumor heterogeneity, which may be best defined by cell subtypes. To test if cell subtypes contributing to progression can be assessed noninvasively, we investigated whether 14 genes representing luminal, neuroendocrine, and stem cells are dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Derderian, Seta, Vesval, Quentin, Wissing, Michel D., Hamel, Lucie, Côté, Nathalie, Vanhuyse, Marie, Ferrario, Cristiano, Bladou, Franck, Aprikian, Armen, Chevalier, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652435/
https://www.ncbi.nlm.nih.gov/pubmed/36172886
http://dx.doi.org/10.1111/cts.13372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652435/
https://www.ncbi.nlm.nih.gov/pubmed/36172886
http://dx.doi.org/10.1111/cts.13372

Ejemplares similares